February 09, 2024
Abdi ibrahim secures a coveted spot as the first turkish pharmaceutical company on the cdp's climate a list
The unrivalled leader in the Turkish pharmaceutical industry for 22 years, Abdi İbrahim attains a noteworthy achievement by earning a coveted spot on the Climate A list within the 2023 Carbon Disclosure Project (CDP) Climate Change Program. For 112 years marked by a passion for progress, Abdi İbrahim has actively embraced the green transformation by diligently integrating environmental considerations into its business models. Aligned with the ambitious 1.5°C target of the Paris Agreement, its greenhouse gas emission reduction targets boast the validation of the Science Based Targets Initiative (SBTi). Aligned with this target, the Company is resolutely aiming to curtail its Scope 1 and Scope 2 greenhouse gas emissions by 60 percent, and its Scope 3 emissions by 45 percent by 2030, measured against the baseline year 2020. Aligned with its HEAL2050 sustainability strategy, the Company remains as committed as ever to achieving its goals of becoming carbon-neutral by 2030 and achieving net-zero by 2050.
Centering its business processes around sustainability with related actions and projects geared towards leaving a more liveable world to future generations, Abdi İbrahim has achieved a significant international success. Abdi İbrahim has earned a prestigious place on the Climate Change Program's A List within the Carbon Disclosure Project (CDP), a global force driving positive change in climate action and natural resource conservation
Founded in 2000 in London, CDP, an international non-profit organization, collaborates with governments, businesses, non-governmental organizations and financial institutions to mitigate the impacts of climate change and safeguard natural resources. Standing proudly among only 346 global companies, Abdi İbrahim broke new ground as the first and only Turkish pharmaceutical company on the Global Climate A List.
Goal: Net Zero Emissions by 2050
Reflecting on Abdi İbrahim's triumph in the Carbon Disclosure Project, Dr. M. Oğuzcan Bülbül, Head of Human Resources, Corporate Communications, and Sustainability Group, remarked: “Since 2020, we have consistently reported to the Carbon Disclosure Project (CDP), earning successive grades of "B-, B and B" in our previous three reports. Our pride swells as we attain the highest and most prestigious accolade within the program, a testament to our unwavering dedication to sustainability. Over 112 years Abdi, İbrahim has been driven by the mission of healing life. While pursuing our economic activities, we prioritize making a 'positive' impact on society and the world we inhabit. We actively contribute to the green transformation by integrating environmental considerations into every facet of our business models, from procurement processes to product launches in the market. In our operations, we strive to actively contribute to solutions addressing both national and international needs, meeting stakeholder expectations in the fight against climate change. Our commitment extends to generating sustainable benefits through projects aligned with circular economy principles. Aligned with the Paris Agreement's ‘1.5°C ’ target, we are resolutely aiming to curtail our Scope 1 and Scope 2 greenhouse gas emissions by 60 percent, and our Scope 3 emissions by 45 percent by 2030, measured against the baseline year 2020. Last year, we became the pioneering and sole Turkish pharmaceutical company whose commitments were endorsed by the Science-Based Targets Initiative (SBTi). Progressing with unwavering determination, we are set to achieve carbon neutrality for Abdi İbrahim by the year 2030. As part of our HEAL2050 strategy, we are also committed to taking our targets one step further and setting a “2050 Net Zero Emission Target” in line with the SBTi Net Zero Standard. Inclusion on the CDP's Climate Change Program A List fills us with immense pride and joy, serving as a powerful validation of our dedicated efforts and forward-thinking vision. With the same dedication that has characterized our efforts for the past 112 years, we will continue in our endeavors to heal life and the future.”
About Abdi İbrahim
Turkish pharmaceutical industry leader Abdi İbrahim’s journey of healing began in a small pharmacy store established by the Pharmacist Abdi İbrahim Bey in Küçükmustafapaşa, Istanbul, in 1912. Today, in addition to its partnerships with more than 30 licensing firms across the globe, Abdi İbrahim develops its own products as well and boasts the largest product portfolio in the industry, with 250 brands and over 500 products. Thanks to its determined vision, dynamic organization, and modern character, Abdi İbrahim has held a leading position in the Turkish pharmaceutical industry since 2002. Today, Abdi İbrahim has subsidiaries operating in 17 countries outside Türkiye, exports to more than 70 countries from the European Union to Canada, North Africa to Asia, and generates the highest employment rate in the Turkish pharmaceutical industry with 5,500 qualified employees. The R&D Center is situated within Abdi İbrahim’s production complex in Esenyurt, Istanbul, which also houses the company’s Chemicals Production Facility, Türkiye’s largest biotechnological manufacturing facility AbdiBio, a Hormone Production Facility, Sterile Ophthalmology & Sterile Inhalation Production Facility, and Chemical, Oncology, and Sterile Supplementary Production Facilities. Abdi İbrahim also has R&D centers and production facilities in Kazakhstan & Algeria.
www.abdiibrahim.com.tr
About CDP
CDP, an international not-for-profit organization established in 2000 in London where it is now headquartered, aims to change the ways of working of the business world in order to reduce the effects of climate change and protect natural resources. Through the CDP, which was initiated to collect and share information that would enable companies, investors and governments to take measures against the threat of climate change, around 18,700 organizations voluntarily disclose data on their greenhouse gas emissions, climate change strategies and sustainable water use to the public and investors. Boasting the world's largest corporate climate change, water and forest-risk data, CDP acts on behalf of 746 investors managing assets worth of US$ 136 trillion as of 2022 and calls on the world's leading companies to disclose their environmental policies. The organization has played an active role in the business world and policymaking processes in recent years not only with its main programs but also with the campaigns and environmental movements it leads around the globe.